Send the following on WhatsApp
Continue to ChatInterim Analysis of a Prospective, Randomized Phase II Trial of Trastuzumab vs Trastuzumab + E75 for the Prevention of Recurrence in HER2 Overexpressing Breast Cancer Patients https://www.sages.org/meetings/annual-meeting/abstracts-archive/interim-analysis-of-a-prospective-randomized-phase-ii-trial-of-trastuzumab-vs-trastuzumab-e75-for-the-prevention-of-recurrence-in-her2-overexpressing-breast-cancer-patients/